Hyperlipoproteinemia Type IIa
What is Hyperlipoproteinemia Type IIa?
Hyperlipoproteinemia Type IIa is a genetic condition that causes very high levels of LDL cholesterol in your blood. LDL stands for low-density lipoprotein, often called bad cholesterol. This condition is also known as familial hypercholesterolemia.
People with Type IIa are born with a genetic change that affects how their liver removes cholesterol from the blood. Even with healthy eating and regular exercise, their cholesterol stays dangerously high. This leads to early buildup of plaque in the arteries, which increases the risk of heart attack and stroke at a young age.
Type IIa is one of the most common inherited lipid disorders. It affects about 1 in 250 people worldwide. Early detection and treatment can significantly reduce cardiovascular risk and help people live longer, healthier lives.
Symptoms
Many people with Hyperlipoproteinemia Type IIa have no symptoms in the early stages. The condition often goes unnoticed until a routine blood test or a cardiovascular event occurs.
- Yellowish deposits around the eyelids, called xanthelasmas
- Fatty deposits on tendons, especially the Achilles tendon and knuckles
- Whitish or grayish ring around the cornea of the eye, called corneal arcus
- Chest pain or angina, especially during physical activity
- Early signs of heart disease in young adults or teenagers
- Family history of heart attacks or strokes before age 55 in men or 65 in women
Some people with Type IIa remain symptom-free for decades. Regular blood testing is the most reliable way to detect this condition before serious complications develop.
Concerned about Hyperlipoproteinemia Type IIa? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Hyperlipoproteinemia Type IIa is caused by genetic mutations that affect how your body processes cholesterol. The most common mutations affect the LDL receptor gene, which controls how the liver removes cholesterol from the blood. When this receptor does not work properly, LDL cholesterol accumulates to dangerous levels. This condition is inherited in an autosomal dominant pattern, meaning you only need one copy of the mutated gene from one parent to develop the condition.
Risk factors include having a parent with the condition, a family history of early heart disease, or physical signs like tendon deposits. While diet and lifestyle matter for overall health, they cannot prevent Type IIa in people with the genetic mutation. The condition affects people of all ethnic backgrounds and both genders equally. Early cholesterol screening is essential for anyone with a family history of high cholesterol or premature cardiovascular disease.
How it's diagnosed
Hyperlipoproteinemia Type IIa is diagnosed through a combination of blood tests and family history. A standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. People with Type IIa typically have LDL cholesterol levels above 190 mg/dL in adults or above 160 mg/dL in children, with normal triglyceride levels. Additional testing for Lipoprotein(a) helps characterize the specific lipid disorder and assess cardiovascular risk more precisely.
Rite Aid offers Lipoprotein(a) testing as an add-on to our preventive health panel. This specialized biomarker measurement helps identify elevated Lp(a), which is common in Type IIa and adds to heart disease risk. Genetic testing can confirm the diagnosis and identify the specific mutation. Your doctor may also look for physical signs like tendon deposits and review your family history of early heart disease.
Treatment options
- Statin medications to lower LDL cholesterol, often at high doses
- Ezetimibe to reduce cholesterol absorption in the intestines
- PCSK9 inhibitors for severe cases that do not respond to statins
- Heart-healthy diet low in saturated fat and trans fat
- Regular aerobic exercise at least 150 minutes per week
- Maintaining a healthy weight and avoiding smoking
- Regular monitoring of lipid levels every 3 to 6 months
- Aspirin therapy in some cases to reduce clotting risk
- Lipoprotein apheresis for very severe cases that do not respond to medication
Treatment should begin as early as possible, often in childhood for those with a confirmed diagnosis. Work with a cardiologist or lipid specialist who can create a personalized treatment plan. Medication combined with lifestyle changes offers the best outcomes and can reduce heart disease risk by up to 80 percent.
Need testing for Hyperlipoproteinemia Type IIa? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Type IIa is a genetic condition you are born with that causes extremely high LDL cholesterol regardless of lifestyle. Regular high cholesterol usually develops over time due to diet, weight, and other lifestyle factors. People with Type IIa often have cholesterol levels above 190 mg/dL even as children or young adults, while typical high cholesterol develops later in life.
You cannot prevent Type IIa because it is inherited through your genes. However, early detection through blood testing can help you start treatment before serious heart damage occurs. If you have a parent with Type IIa, you have a 50 percent chance of inheriting the condition. Getting tested early allows for preventive treatment that can dramatically reduce your risk of heart attack and stroke.
Children with a family history of Type IIa or early heart disease should have their cholesterol tested between ages 2 and 10. The American Academy of Pediatrics recommends universal cholesterol screening for all children between ages 9 and 11. Early diagnosis allows treatment to begin before artery damage accumulates, which can add decades to a child's life expectancy.
Lipoprotein(a) or Lp(a) is a special type of cholesterol particle that increases heart disease risk. Many people with Type IIa also have elevated Lp(a), which adds to their cardiovascular risk beyond LDL cholesterol alone. Testing Lp(a) levels helps your doctor understand your complete risk profile and adjust treatment accordingly. Unlike LDL, Lp(a) levels are largely determined by genetics and do not respond well to diet or most medications.
Diet and exercise are important for overall heart health but will not lower cholesterol to safe levels if you have Type IIa. People with this genetic condition need medication to bring their LDL cholesterol down to target ranges. That said, a heart-healthy lifestyle still matters because it improves blood vessel health, reduces inflammation, and enhances the effectiveness of cholesterol-lowering medications.
For people with Type IIa, doctors typically aim for LDL cholesterol below 100 mg/dL, and often below 70 mg/dL if other risk factors are present. These targets are much lower than for people without this condition. Your doctor may also set goals for total cholesterol, HDL cholesterol, and triglycerides. Regular blood testing every 3 to 6 months helps track whether treatment is working and if adjustments are needed.
Yes, Hyperlipoproteinemia Type IIa is the same condition as familial hypercholesterolemia or FH. The terms are used interchangeably in medical literature. Both refer to the inherited form of extremely high LDL cholesterol caused by genetic mutations affecting cholesterol processing. The condition is sometimes called heterozygous FH when you inherit one copy of the mutated gene, or homozygous FH when you inherit two copies.
Yes, untreated Type IIa significantly increases the risk of heart attacks in young adults, sometimes even in teenagers. Men with untreated Type IIa often have heart attacks in their 40s or 50s, while women typically develop problems 10 to 15 years later. With proper treatment started early, this risk can be reduced by up to 80 percent. Early detection and aggressive cholesterol management are essential for preventing premature cardiovascular events.
Statins are the first-line treatment and can lower LDL cholesterol by 30 to 50 percent. Many people also need ezetimibe, which blocks cholesterol absorption and can lower LDL by an additional 15 to 20 percent. For severe cases, PCSK9 inhibitors are injectable medications that can lower LDL by another 50 to 60 percent. Your doctor will choose medications based on your cholesterol levels, other risk factors, and how well you respond to treatment.
Yes, all first-degree relatives including parents, siblings, and children should be tested for Type IIa. Each family member has a 50 percent chance of inheriting the condition if you have it. Cascade screening, where family members are tested after one person is diagnosed, helps identify others who need treatment. Early identification and treatment in family members can prevent heart attacks and strokes before they occur.